Join
Live feed
·
PRReleasevia Quantisnow
Precigen Inc. logo

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

ByQuantisnow·Wall Street's wire, on your screen.
PGEN· Precigen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PGEN (Precigen Inc.) and more on Quantisnow.